Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis

Leuk Lymphoma. 2007 Feb;48(2):437-8. doi: 10.1080/10428190601078134.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chlorambucil / administration & dosage
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Chlorambucil
  • Rituximab